A rendering of Biogen’s future headquarters in MIT’s Kendall Common development in Kendall Square.
Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty, which would consolidate the biotech giant's once-sprawling operations in the neighborhood.
The company will occupy the entirety of the first building that will go up in MIT's Kendall Common, a 10-acre mixed-use development that the university's real estate arm is set to build on what was long the Volpe transportation complex. The 15-year lease is for 580,000 square feet.
WATCH ANYTIME FOR FREE
 |
Stream NBC10 Boston news for free, 24/7, wherever you are. |
The move is expected to take place in 2028, after construction of 75 Broadway is complete.
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
